Category - Study

FDA Fails to Provide Credible Data and Science to Justify Scheduling Kratom as Schedule I Substance

6 years ago

House Study Committee on Risks Associated with Kratom sets final meeting

6 years ago

Senate Study Committee on the risks Associated with Kratom

7 years ago

UF College of Pharmacy receives $3.5 million NIDA grant to bolster kratom research

7 years ago

American Kratom Association Demands a Recall on Scheduling Recommendation and Complete FDA Re-evaluation of Kratom Science

7 years ago